BRIEF-Hemispherx Biopharma renews sales, marketing, distribution and supply agreement with GP Pharm
May 31 (Reuters) - Hemispherx Biopharma Inc
* Renews sales, marketing, distribution and supply agreement with GP Pharm
* Granted GP Pharm expanded rights to sell ampligen into other Latin American countries based upon certain performance milestones
* Has also granted GP Pharm an option to market alferon n injection trademarked in Argentina as naturaferon
* GP Pharm will be responsible for gaining regulatory approval in Argentina for ampligen, an experimental therapeutic Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.